SEC Form 4 · accession 0001493152-17-014433
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond F Schinazi
Director
Period of report
Nov 24, 2017
Accepted (ET)
Dec 8, 2017 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8% Convertible Note | $0.27 | Nov 24, 2017 | A | 1,851,851 | A | Nov 24, 2017 | Nov 24, 2019 | Common Stock | 1,851,851 | 1,851,851 | I |